Find the exact order
Save the DEN number, device name, requester and decision date from the FDA De Novo record. The search result is an index; the detail record is the evidence.
Device evidence · November 6, 2026
A granted De Novo request establishes a classification for a new device type. It does not, by itself, prove that a seller's model, intended use or current configuration is the device described in the order.
Three separate questions
Save the DEN number, device name, requester and decision date from the FDA De Novo record. The search result is an index; the detail record is the evidence.
Read the classification order for the generic type, class, indication and special controls. The detail record links to the order and, when available, the FDA decision summary.
Compare the quotation's model, version, intended use and claims. A product code or family name alone does not establish that match.
Scope guard: A De Novo classification is not a supplier endorsement, a clinical recommendation or proof of authorization in another country. Keep any missing model or labeling connection unresolved.
Worked example · historical U.S. FDA order
The April 11, 2018 classification order is a useful reading example because it contains the device type, indications and special controls. It does not establish today's labeling, a current seller or a unit offered today.
DEN180001 · April 11, 2018
Order · page 1
The order describes use by health care providers to automatically detect more than mild diabetic retinopathy in adults diagnosed with diabetes who have not previously been diagnosed with diabetic retinopathy. It specifies use with the Topcon NW400.
It identifies a prescription device. The generic device type is broader than this particular indication; do not substitute one for the other.
Unit: one historical classification order and its FDA detail record, not a count of manufacturers, sales, clinical outcomes or market size. Geography: U.S. FDA-market decision; requester location in the record is Iowa City, Iowa, United States. Consulted November 6, 2026. The location does not establish authorization in another country.
Special controls · selected examples, not the complete list
Pages 2–4 of the order set out controls for the device type. These selected examples explain why a class label alone cannot answer a buying question. They are requirements in the order, not a report that a seller's product was tested.
Read the full document: the order also addresses clinical performance, technical-specification changes and additional labeling. This selection is a reading aid, not a compliance checklist or a determination that a current device satisfies the controls.
Fictional quotation · not a real seller
Suppose a quotation cites DEN180001 for an IDx-DR system “with any retinal camera.” The order identifies Topcon NW400. That historical document alone does not support the broader compatibility claim.
DEN180001 was located. Page 1 names the indication, patient population and Topcon NW400; pages 2–4 specify controls. This does not prove that no later change exists.
Keep the quotation's camera model and software version. Request applicable current labeling and the official record supporting the offered configuration. A missing connection stays unresolved.
Use a precise note: “Historical De Novo order located; offered camera and software configuration not established by this order.” Do not turn a missing connection into either a current authorization or a finding of noncompliance.
A reproducible handoff
Use the supplier evidence worksheet for the packet and the FDA certification guide to separate device evidence from establishment evidence.
Primary sources and limits
Consulted November 6, 2026. This is an informational reading example. It does not establish a current supplier, clinical performance, inventory, foreign authorization or complete history of later changes.